# Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy

> **NCT01577212** · PHASE2 · TERMINATED · sponsor: **Radboud University Medical Center** · enrollment: 6 (actual)

## Conditions studied

- Stage III Non-small Cell Lung Cancer
- Individualized Radiation Dose Escalation

## Interventions

- **RADIATION:** Individualized dose escalation

## Key facts

- **NCT ID:** NCT01577212
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2015-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01577212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01577212, "Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01577212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*